Hubei Enoray

Hubei Enoray Biopharmaceutical is a specialized pharmaceutical company based in China, focusing on the development and manufacture of heparin-based anticoagulants. The company operates across the full production chain, from the extraction of crude heparin to the manufacturing of high-purity Active Pharmaceutical Ingredients (APIs) and finished injectable products such as Enoxaparin Sodium. Their state-of-the-art facilities are built to comply with international GMP standards, enabling them to supply critical antithrombotic medications to both domestic and international markets. Enoray is recognized for its technical expertise in low molecular weight heparin (LMWH) production and purification. The company's portfolio includes a range of heparin sodium and low molecular weight heparin products used in the treatment of deep vein thrombosis and pulmonary embolism. By integrating R&D with large-scale manufacturing, Hubei Enoray aims to become a leading global supplier in the heparin industrial chain.